Regulatory interventions aimed at curbing counterfeit and compounded products may lead to disruptions in supply chains, changes in prescribing behaviors, and increased scrutiny of off-label prescribing
Most patients notice appetite changes within the first 12 weeks
Otherwise, patients will discuss the treatment plan with their provider including diet and exercise changes, possible side effects, and proper administration
None of these medications are recommended during pregnancy or breastfeeding
The only current, as of March 2023, GIP is tirzepatide which has the brand name Mounjaro
NICE TA875 and NHS patient materials note that redness, itching, or mild bruising are common early reactions